LiDCO Group Plc

("LiDCO" or the "Company")

LiDCO study day receives Royal College of Nursing accreditation

LiDCO Group Plc (AIM: LID), the hemodynamic monitoring company, is pleased to announce accreditation from the Royal College of Nursing ("RCN") for its LiDCOplus monitor competency based study day.  Gaining this prestigious accreditation is a major step forward for LiDCO towards its goal of offering superior products supported by excellence in clinical education. 

Dr Terry O'Brien, CEO of LiDCO, commented:  "With the completion of the pre-course material, this full day off-site program provides nine hours of training towards each nurses PREP (post-registration education and practice) requirements.  The course is competency based and designed for all critical care nurses, nurse educators, professional development nurses, nurse consultants and junior doctors.  Content covers anatomy and physiology, interpretation of information, equipment set-up and management.  

"The LiDCO course is evidence-based in line with the British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients ("GIFTASUP") and, in combination with use of the LiDCOrapid and LiDCOplus cardiac output monitors, helps hospitals to follow the Department of Health's recommendations to all NHS chief executives to adopt enhanced recovery or goal-directed therapy programs, which are designed to improve patient outcomes and reduce treatment costs."

- ENDS -

For more information please contact:

Media enquiries

About LiDCO Group Plc

LiDCO is a leading supplier of minimally invasive hemodynamic monitoring equipment and disposables. These are used primarily for the management of hospital patients requiring critical care or at major cardiovascular risk. LiDCO's computer-based technology significantly reduces the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. LiDCO is based in the UK and its shares are traded on AIM. For more information please see www.lidco.com.

The Company's manufacturing facility is in Hoxton, London and its current products are:

* LiDCOplus is a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid-volume responsiveness (PPV% and SVV%)

* LiDCOrapid: our new cardiac output monitor designed specifically for use in the Operating Theatre for fluid and drug management at the point of care. The monitor features many clinical benefits. These enable acute-care physicians to get accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being during and after surgery. These benefits are:

* LiDCO single-patient-use disposables used in conjunction with the LiDCOplus and LiDCOrapid Monitors.

* LiDCOview: an easy-to-use graphical display of historical LiDCOplus hemodynamic data. Both clinical researchers and routine users can view beat-to-beat hemodynamic data collected with the LiDCOplus.

LiDCO Distribution Network:

The Company sells direct to hospitals in the UK, and elsewhere through a worldwide network of speciality critical care and anesthesia distributors